Fixed Phage accelerates growth strategy with appointment of new CEO and top team

Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its new Chief Executive Officer (CEO). The company has also announced its new Chief Operations Officer (COO) and Executive Chairman. These appointments strengthen the top management team, leading the company as it drives forward its new phase of growth and development. Dr…


New backing accelerates Fixed Phage’s fight against harmful bacteria

Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight against new microbial threats that pose risks to human health and agricultural production. The company, based in Glasgow, has developed an innovative, cost-effective technology that makes bacteriophages – natural antimicrobials – able to eliminate problem bacteria. The patented solution has…